Back

Can GLP-1 receptor agonists improve crude outcomes associated with heart failure? A meta-analysis of randomized controlled trials comprising 78,806 patients

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure 1 Prevention HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Marko Kumric

University of Split School of Medicine, Split (Croatia)

5 More presentations in this session

Presentation thumbnail
Rising (pep)tides, failing hearts: serial BNP alterations as harbingers in stage A preclinical heart failure
Doctor A. Moore (Dublin, IE)
Abstract Slides Video
Presentation thumbnail
Assessing the knowledge, attitude, and practice of frontline physicians in Egyptian university hospitals regarding pharyngitis and acute rheumatic fever: a cross-sectional study that calls for action
Doctor K. Abdelsayed (Minneapolis, US)
Abstract Slides Video
Presentation thumbnail
Association of healthy diet score with left ventricle structure and function in cardiac magnetic resonance imaging: results from UK Biobank
Miss P. Nowek (Olsztyn, PL)
Abstract Slides Video
Presentation thumbnail
2021 ESC Guidelines on HF recommendations in daily practice: a survey results. A clinical scientific statement of the Heart Failure Association of the ESC and the Council for Cardiology Practice
Doctor R. Christodorescu (Timisoara, RO)
Abstract Slides Video
Presentation thumbnail
Differences in effectiveness of non-invasive remote monitoring modalities in patients with chronic heart failure: a meta-regression
Mr N. Scholte (Rotterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure 1

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
The effect of glucagon-like peptide-1 receptor agonists on patients with heart failure with reduced ejection fraction
thumbnail
Congress Presentation
GLP-1 receptor agonists for obesity-related heart failure with preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials
thumbnail
Congress Presentation
GLP-1 RAs reduce mortality and cardiovascular events across the spectrum of treated patients: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources